Systematic screening of common wastewater-marking pharmaceuticals in urban aquatic environments: Implications for environmental risk control

Environmental Science and Pollution Research

Volumn 21, Issue 11, 2014, Pages 7113-7129

  Zhou, Haidong ^a   Zhang, Qingjun ^a   Wang, Xuelian ^a   Zhang, Qianqian ^a   Ma, Lixin ^a   Zhan, Yong ^a  

^a UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bioconcentration; Eco toxicity; Environmental risk; Risk quotient; Screening system; Wastewater treatment plant

Indexed keywords

ADSORPTION; AQUATIC ENVIRONMENT; BIOACCUMULATION; DRUG; ECOTOXICOLOGY; ENVIRONMENTAL ASSESSMENT; ENVIRONMENTAL RISK; NONPOINT SOURCE POLLUTION; ORGANIC CARBON; POLLUTION CONTROL; SEWAGE TREATMENT; WASTEWATER; WATER POLLUTION;

DRUG; SEWAGE; WASTE WATER; WATER POLLUTANT;

ADVERSE DRUG REACTION; ANALYSIS; CHEMISTRY; CITY; CLASSIFICATION; ENVIRONMENT; ENVIRONMENTAL MONITORING; PROCEDURES; RISK ASSESSMENT; SEWAGE; WASTE WATER; WATER POLLUTANT; WATER POLLUTION;

CITIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ENVIRONMENT; ENVIRONMENTAL MONITORING; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; SEWAGE; WASTE WATER; WATER POLLUTANTS, CHEMICAL; WATER POLLUTION;

EID: 84901253706     PISSN: 09441344     EISSN: 16147499     Source Type: Journal    
DOI: 10.1007/s11356-014-2622-4     Document Type: Article

References (171)

1. Adelowo OO, Fagade OE (2009) The tetracycline resistance gene tet39 is present in both Gram-negative and Gram-positive bacteria from a polluted river, Southwestern Nigeria. Lett Appl Microbiol 48(2): 167-172.
2. Andreozzi R, Marotta R, Paxeus N (2003) Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50(10): 1319-1330.
3. Araujo L, Villa N, Camargo N, Bustos M, Garcia T, de Jesus PA (2011) Persistence of gemfibrozil, naproxen and mefenamic acid in natural waters. Environ Chem Lett 9(1): 13-18.
4. Ashton D, Hilton M, Thomas KV (2004) Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 333(1-3): 167-184.
5. Baranowska I, Kowalski B (2009) An analytical procedure for the determination of different therapeutic drugs in surface waters. Water Sci Technol 60(2): 449-458.
6. Baranowska I, Kowalski B (2011) Using HPLC method with DAD detection for the simultaneous determination of 15 drugs in surface water and wastewater. Pol J Environ Stud 20(1): 21-28.
7. Baranowska I, Wojciechowska I (2012) Development of SPE/HPLC-DAD to determine residues of selected disinfectant agents in surface water. Pol J Environ Stud 21(2): 269-277.
8. Bartels P, Von Tuempling W Jr (2007) Solar radiation influence on the decomposition process of diclofenac in surface waters. Sci Total Environ 374(1): 143-155.
9. Bartelt-Hunt S, Snow DD, Damon-Powell T, Miesbach D (2011) Occurrence of steroid hormones and antibiotics in shallow groundwater impacted by livestock waste control facilities. J Contam Hydrol 123(3-4): 94-103.
10. Bartelt-Hunt SL, Snow DD, Damon T, Shockley J, Hoagland K (2009) The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska. Environ Pollut 157(3): 786-791.
11. Batt AL, Aga DS (2005) Simultaneous analysis of multiple classes of antibiotics by ion trap LC/MS/MS for assessing surface water and groundwater contamination. Anal Chem 77(9): 2940-2947.
12. Bendz D, Paxeus NA, Ginn TR, Loge FJ (2005) Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J Hazard Mater 122(3): 195-204.
13. Bergheim M, Giere R, Kuemmerer K (2012) Biodegradability and ecotoxicity of tramadol, ranitidine, and their photoderivatives in the aquatic environment. Environ Sci Pollut Res 19(1): 72-85.
14. Berset J-D, Brenneisen R, Mathieu C (2010) Analysis of licit and illicit drugs in waste, surface and lake water samples using large volume direct injection high performance liquid chromatography-electrospray tandem mass spectrometry (HPLC-MS/MS). Chemosphere 81(7): 859-866.
15. Boillot C, Bazin C, Tissot-Guerraz F, Droguet J, Perraud M, Cetre JC, Trepo D, Perrodin Y (2008) Daily physicochemical, microbiological and ecotoxicological fluctuations of a hospital effluent according to technical and care activities. Sci Total Environ 403(1-3): 113-129.
16. Botello I, Borrull F, Aguilar C, Calull M (2012) Investigation of in-line solid-phase extraction capillary electrophoresis for the analysis of drugs of abuse and their metabolites in water samples. Electrophoresis 33(3): 528-535.
17. Boxall A (2003) Prioritisation of veterinary medicines in the UK environment. Toxicol Lett 142(3): 207-218.
18. Buser HR, Poiger T, Muller MD (1999) Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 33(15): 2529-2535.
19. Calza P, Marchisio S, Medana C, Baiocchi C (2010) Fate of antibacterial spiramycin in river waters. Anal Bioanal Chem 396(4): 1539-1550.
20. Caracciolo AB, Grenni P, Falconi F, Caputo MC, Ancona V, Uricchio VF (2011) Pharmaceutical waste disposal: assessment of its effects on bacterial communities in soil and groundwater. Chem Ecolog 27: 43-51.
21. Carlsson C, Johansson A-K, Alvan G, Bergman K, Kühler T (2006) Are pharmaceuticals potent environmental pollutants? Sci Total Environ 364(1-3): 67-87.
22. Chen H-C, Wang P-L, Ding W-H (2008) Using liquid chromatography-ion trap mass spectrometry to determine pharmaceutical residues in Taiwanese rivers and wastewaters. Chemosphere 72(6): 863-869.
23. Chen H, Li X, Zhu S (2012) Occurrence and distribution of selected pharmaceuticals and personal care products in aquatic environments: a comparative study of regions in China with different urbanization levels. Environ Sci Pollut Res 19(6): 2381-2389.
24. Choi K, Kim Y, Jung J, Kim MH, Kim CS, Kim NH, Park J (2008a) Occurrences and ecological risks of roxithromycin, trimethoprim, and chloramphenicol in the Han River, Korea. Environ Toxicol Chem 27(3): 711-719.
25. Choi K, Kim Y, Park J, Park CK, Kim M, Kim HS, Kim P (2008b) Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea. Sci Total Environ 405(1-3): 120-128.
26. Christian T, Schneider RJ, Farber HA, Skutlarek D, Meyer MT, Goldbach HE (2003) Determination of antibiotic residues in manure, soil, and surface waters. Acta Hydrochim Hydrobiol 31(1): 36-44.
27. Cleuvers M (2005) Initial risk assessment for three beta-blockers found in the aquatic environment. Chemosphere 59(2): 199-205.
28. Comoretto L, Chiron S (2005) Comparing pharmaceutical and pesticide loads into a small Mediterranean river. Sci Total Environ 349(1-3): 201-210.
29. Conley JM, Symes SJ, Schorr MS, Richards SM (2008) Spatial and temporal analysis of pharmaceutical concentrations in the upper Tennessee River basin. Chemosphere 73(8): 1178-1187.
30. Costanzo SD, Murby J, Bates J (2005) Ecosystem response to antibiotics entering the aquatic environment. Mar Pollut Bull 51(1-4): 218-223.
31. Daneshvar A, Svanfelt J, Kronberg L, Prevost M, Weyhenmeyer GA (2010) Seasonal variations in the occurrence and fate of basic and neutral pharmaceuticals in a Swedish river-lake system. Chemosphere 80(3): 301-309.
32. Daughton CG (2010) Pharmaceutical ingredients in drinking water: overview of occurrence and significance of human exposure. In: Halden RU (ed) Contaminants of emerging concern in the environment: ecological and human health considerations, Vol 1048. ACS Symposium Series. pp 9-68.
33. de Jongh CM, Kooij PJF, de Voogt P, ter Laak TL (2012) Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water. Sci Total Environ 427: 70-77.
34. de Voogt P, Janex-Habibi ML, Sacher F, Puijker L, Mons M (2009) Development of a common priority list of pharmaceuticals relevant for the water cycle. Water Sci Technol 59(1): 39-46.
35. DellaGreca M, Iesce MR, Previtera L, Rubino M, Temussi F, Brigante M (2006) Degradation of lansoprazole and omeprazole in the aquatic environment. Chemosphere 63(7): 1087-1093.
36. Erdogan H, Can F, Demirbilek M, Timurkaynak F, Arslan H (2010) In vitro activity of antimicrobial agents against Legionella isolated from environmental water systems: first results from Turkey. Environ Monit Assess 171(1-4): 487-491.
37. Escher BI, Baumgartner R, Koller M, Treyer K, Lienert J, McArdell CS (2011) Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res 45(1): 75-92.
38. Estevez E, del Carmen CM, Molina-Diaz A, Robles-Molina J, del Pino P-DM (2012) Screening of emerging contaminants and priority substances (2008/105/EC) in reclaimed water for irrigation and groundwater in a volcanic aquifer (Gran Canaria, Canary Islands, Spain). Sci Total Environ 433: 538-546.
39. Faisal M, Loch TP, Brenden TO, Eissa AE, Ebener MP, Wright GM, Jones ML (2010) Assessment of Renibacterium salmoninarum infections in four lake whitefish (Coregonus clupeaformis) stocks from northern Lakes Huron and Michigan. J Gt Lakes Res 36: 29-37.
40. Fernandez C, Gonzalez-Doncel M, Pro J, Carbonell G, Tarazona JV (2010) Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo River System (Madrid, Spain) and a potential risk characterization. Sci Total Environ 408(3): 543-551.
41. Ferrari B, Mons R, Vollat B, Fraysse B, Paxeus N, Lo Giudice R, Pollio A, Garric J (2004) Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Toxicol Chem 23(5): 1344-1354.
42. Ferrari B, Paxéus N, Giudice RL, Pollio A, Garric J (2003) Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol Environ Saf 55(3): 359-370.
43. Ferreira da Silva B, Jelic A, Lopez-Serna R, Mozeto AA, Petrovic M, Barcelo D (2011) Occurrence and distribution of pharmaceuticals in surface water, suspended solids and sediments of the Ebro river basin, Spain. Chemosphere 85(8): 1331-1339.
44. Fono LJ, Kolodziej EP, Sedlak DL (2006) Attenuation of wastewater-derived contaminants in an effluent-dominated river. Environ Sci Technol 40(23): 7257-7262.
45. Fono LJ, Sedlak DL (2005) Use of the chiral pharmaceutical propranolol to identik sewage discharges into surface waters. Environ Sci Technol 39(23): 9244-9252.
46. Fram MS, Belitz K (2011) Occurrence and concentrations of pharmaceutical compounds in groundwater used for public drinking-water supply in California. Sci Total Environ 409(18): 3409-3417.
47. Gao L, Shi Y, Li W, Liu J, Cai Y (2012a) Occurrence, distribution and bioaccumulation of antibiotics in the Haihe River in China. J Environ Monit 14(4): 1248-1255.
48. Gao P, Mao D, Luo Y, Wang L, Xu B, Xu L (2012b) Occurrence of sulfonamide and tetracycline-resistant bacteria and resistance genes in aquaculture environment. Water Res 46(7): 2355-2364.
49. Garcia-Ac A, Segura PA, Viglino L, Furtos A, Gagnon C, Prevost M, Sauve S (2009) On-line solid-phase extraction of large-volume injections coupled to liquid chromatography-tandem mass spectrometry for the quantitation and confirmation of 14 selected trace organic contaminants in drinking and surface water. J Chromatogr A 1216(48): 8518-8527.
50. Garcia-Armisen T, Vercammen K, Passerat J, Triest D, Servais P, Cornelis P (2011) Antimicrobial resistance of heterotrophic bacteria in sewage-contaminated rivers. Water Res 45(2): 788-796.
51. Ginebreda A, Munoz I, Lopez de Alda M, Brix R, Lopez-Doval J, Barcelo D (2010) Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). Environ Int 36(2): 153-162.
52. Githinji LJM, Musey MK, Ankumah RO (2011) Evaluation of the fate of ciprofloxacin and amoxicillin in domestic wastewater. Water Air Soil Pollut 219(1-4): 191-201.
53. Gomez-Ramos MdM, Perez-Parada A, Garcia-Reyes JF, Fernandez-Alba AR, Aguera A (2011) Use of an accurate-mass database for the systematic identification of transformation products of organic contaminants in wastewater effluents. J chromatogr A 1218(44): 8002-8012.
54. Gottschall N, Topp E, Metcalfe C, Edwards M, Payne M, Kleywegt S, Russell P, Lapen DR (2012) Pharmaceutical and personal care products in groundwater, subsurface drainage, soil, and wheat grain, following a high single application of municipal biosolids to a field. Chemosphere 87(2): 194-203.
55. Gracia-Lor E, Sancho JV, Serrano R, Hernandez F (2012) Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia. Chemosphere 87(5): 453-462.
56. Gros M, Petrovic M, Barcelo D (2007) Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the ebro river basin (northeast Spain). Environ Toxicol Chem 26(8): 1553-1562.
57. He X, Wang Z, Nie X, Yang Y, Pan D, Leung AOW, Cheng Z, Yang Y, Li K, Chen K (2012) Residues of fluoroquinolones in marine aquaculture environment of the Pearl River Delta, South China. Environ Geochem Health 34(3): 323-335.
58. Hernando M, Mezcua M, Fernandezalba A, Barcelo D (2006) Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 69(2): 334-342.
59. Hou YM, Yan YS (2011) Phase-Separation floatation spectrophotometric determination of trace chlortetracycline in river. Proceedings of the 2011 Second International Conference on Digital Manufacturing and Automation (ICDMA 2011): 848-850.
60. Huang Q, Yu Y, Tang C, Zhang K, Cui J, Peng X (2011) Occurrence and behavior of non-steroidal anti-inflammatory drugs and lipid regulators in wastewater and urban river water of the Pearl River Delta, South China. J Environ Monit 13(4): 855-863.
61. Isidori M, Bellotta M, Cangiano M, Parrella A (2009) Estrogenic activity of pharmaceuticals in the aquatic environment. Environ Int 35(5): 826-829.
62. Ji K, Kim S, Han S, Seo J, Lee S, Park Y, Choi K, Kho YL, Kim PG, Park J, Choi K (2012) Risk assessment of chlortetracycline, oxytetracycline, sulfamethazine, sulfathiazole, and erythromycin in aquatic environment: are the current environmental concentrations safe? Ecotoxicology 21(7): 2031-2050.
63. Jiang L, Hu X, Yin D, Zhang H, Yu Z (2011) Occurrence, distribution and seasonal variation of antibiotics in the Huangpu River, Shanghai, China. Chemosphere 82(6): 822-828.
64. Jones OAH, Voulvoulis N, Lester JN (2002a) Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res 36: 5013-5022.
65. Jones OAH, Voulvoulis N, Lester JN (2002b) Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res 36(20): 5013-5022.
66. Joss A, Keller E, Alder AC, Gobel A, McArdell CS, Ternes T, Siegrist H (2005) Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 39(14): 3139-3152.
67. Kahle M, Buerge IJ, Hauser A, Mueller MD, Poiger T (2008) Azole fungicides: occurrence and fate in wastewater and surface waters. Environ Sci Technol 42(19): 7193-7200.
68. Kasprzyk-Hordern B, Baker DR (2012) Enantiomeric profiling of chiral drugs in wastewater and receiving waters. Environ Sci Technol 46(3): 1681-1691.
69. Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ (2008a) The effect of signal suppression and mobile phase composition on the simultaneous analysis of multiple classes of acidic/neutral pharmaceuticals and personal care products in surface water by solid-phase extraction and ultra performance liquid chromatography-negative electrospray tandem mass spectrometry. Talanta 74(5): 1299-1312.
70. Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ (2008b) The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res 42(13): 3498-3518.
71. Khalaf H, Salste L, Karlsson P, Ivarsson P, Jass J, Olsson P-E (2009) In vitro analysis of inflammatory responses following environmental exposure to pharmaceuticals and inland waters. Sci Total Environ 407(4): 1452-1460.
72. Kim JW, Ishibashi H, Yamauchi R, Ichikawa N, Takao Y, Hirano M, Koga M, Arizono K (2009) Acute toxicity of pharmaceutical and personal care products on freshwater crustacean (Thamnocephalus platyurus) and fish (Oryzias latipes). J Toxicol Sci 34(2): 227-232.
73. Kim SD, Cho J, Kim IS, Vanderford BJ, Snyder SA (2007a) Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res 41(5): 1013-1021.
74. Kim Y, Choi K, Jung J, Park S, Kim P-G, Park J (2007b) Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environ Int 33(3): 370-375.
75. Kimura A, Osawa M, Taguchi M (2012) Decomposition of persistent pharmaceuticals in wastewater by ionizing radiation. Radiat Phys Chem 81(9): 1508-1512.
76. Kinney CA, Furlong ET, Werner SL, Cahill JD (2006) Presence and distribution of wastewater-derived pharmaceuticals in soil irrigated with reclaimed water. Environ Toxicol Chem 25(2): 317-326.
77. Kosonen J, Kronberg L (2009) The occurrence of antihistamines in sewage waters and in recipient rivers. Environ Sci Pollut Res 16(5): 555-564.
78. Kuemmerer K (2010) Pharmaceuticals in the Environment. In: Gadgil A, Liverman DM (eds) Annual Review of Environment and Resources, Vol 35. pp 57.
79. Kumar A, Xagoraraki I (2010) Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U. S. surface and finished drinking waters: a proposed ranking system. Sci Total Environ 408(23): 5972-5989.
80. Kunkel U, Radke M (2011) Reactive tracer test to evaluate the fate of pharmaceuticals in rivers. Environ Sci Technol 45(15): 6296-6302.
81. Kuster M, Lopez J, de Alda M, Dolores Hernando M, Petrovic M, Martin-Alonso J, Barcelo D (2008) Analysis and occurrence of pharmaceuticals, estrogens, progestogens and polar pesticides in sewage treatment plant effluents, river water and drinking water in the Llobregat river basin (Barcelona, Spain). J Hydrol 358(1-2): 112-123.
82. Lacey C, Basha S, Morrissey A, Tobin JM (2012) Occurrence of pharmaceutical compounds in wastewater process streams in Dublin, Ireland. Environ Monit Assess 184(2): 1049-1062.
83. Lahti M, Brozinski JM, Segner H, Kronberg L, Oikari A (2012) Bioavailability of pharmaceuticals in waters close to wastewater treatment plants: use of fish bile for exposure assessment. Environ Toxicol Chem 31(8): 1831-1837.
84. Lang J, Kohidai L (2012) Effects of the aquatic contaminant human pharmaceuticals and their mixtures on the proliferation and migratory responses of the bioindicator freshwater ciliate Tetrahymena. Chemosphere 89(5): 592-601.
85. Langford K, Thomas KV (2011) Input of selected human pharmaceutical metabolites into the Norwegian aquatic environment. J Environ Monit 13(2): 416-421.
86. Lee YJ, Lee SE, Lee DS, Kim YH (2008) Risk assessment of human antibiotics in Korean aquatic environment. Environ Toxicol Pharmacol 26(2): 216-221.
87. Lenz K, Koellensperger G, Hann S, Weissenbacher N, Mahnik SN, Fuerhacker M (2007) Fate of cancerostatic platinum compounds in biological wastewater treatment of hospital effluents. Chemosphere 69(11): 1765-1774.
88. Li W, Shi Y, Gao L, Liu J, Cai Y (2012) Investigation of antibiotics in mollusks from coastal waters in the Bohai Sea of China. Environ Pollut 162: 56-62.
89. Lim MH, Snyder SA, Sedlak DL (2008) Use of biodegradable dissolved organic carbon (BDOC) to assess the potential for transformation of wastewater-derived contaminants in surface waters. Water Res 42(12): 2943-2952.
90. Lin AYC, Panchangam SC, Chen H-Y (2010) Implications of human pharmaceutical occurrence in the Sindian river of Taiwan: a strategic study of risk assessment. J Environ Monit 12(1): 261-270.
91. Lin AYC, Tsai YT, Yu TH, Wang XH, Lin CF (2011) Occurrence and fate of pharmaceuticals and personal care products in Taiwan's aquatic environment. Desalin Water Treat 32(1-3): 57-64.
92. Lindqvist N, Tuhkanen T, Kronberg L (2005) Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res 39(11): 2219-2228.
93. Lopez-Serna R, Postigo C, Blanco J, Perez S, Ginebreda A, Lopez de Alda M, Petrovic M, Munne A, Barcelo D (2012) Assessing the effects of tertiary treated wastewater reuse on the presence emerging contaminants in a Mediterranean river (Llobregat, NE Spain). Environ Sci Pollut Res 19(4): 1000-1012.
94. Lu S, Li T, Zhou H (2010) Diversity changes of the microbial communities and bla(CTX-M) genes in urban river sediments treated with cefotaxime. J South Med Univ 30(3): 463-467 (In Chinese).
95. Lu XW, Dang Z, Yang C (2009) Preliminary investigation of chloramphenicol in fish, water and sediment from freshwater aquaculture pond. Int J Environ Sci Technol 6(4): 597-604.
96. Luczkiewicz A, Jankowska K, Kurlenda J, Olanczuk-Neyman K (2010) Identification and antimicrobial resistance of Enterococcus spp. isolated from surface water. Water Sci Technol 62(2): 466-473.
97. Luczkiewicz A, Jankowska K, Kurlenda J, Olanczuk-Neyman K (2011) Identification and antimicrobial susceptibility of fecal coliforms isolated from surface water. Pol J Environ Stud 20(4): 941-950.
98. Luo Y, Xu L, Rysz M, Wang Y, Zhang H, Alvarez PJJ (2011) Occurrence and transport of tetracycline, sulfonamide, quinolone, and macrolide antibiotics in the Haihe River Basin, China. Environ Sci Technol 45(5): 1827-1833.
99. Macleod SL, McClure EL, Wong CS (2007) Laboratory calibration and field deployment of the polar organic chemical integrative sampler for pharmaceuticals and personal care products in wastewater and surface water. Environ Toxicol Chem 26(12): 2517-2529.
100. Madureira TV, Barreiro JC, Rocha MJ, Rocha E, Cass QB, Tiritan ME (2010) Spatiotemporal distribution of pharmaceuticals in the Douro River estuary (Portugal). Sci Total Environ 408(22): 5513-5520.
101. Madureira TV, Rocha MJ, Cruzeiro C, Rodrigues I, Monteiro RAF, Rocha E (2012) The toxicity potential of pharmaceuticals found in the Douro River estuary (Portugal): evaluation of impacts on fish liver, by histopathology, stereology, vitellogenin and CYP1A immunohistochemistry, after sub-acute exposures of the zebrafish model. Environ Toxicol Pharmacol 34(1): 34-45.
102. Maeng SK, Sharma SK, Lekkerkerker-Teunissen K, Amy GL (2011) Occurrence and fate of bulk organic matter and pharmaceutically active compounds in managed aquifer recharge: a review. Water Res 45(10): 3015-3033.
103. Magner J, Filipovic M, Alsberg T (2010) Application of a novel solid-phase-extraction sampler and ultra-performance liquid chromatography quadrupole-time-of-flight mass spectrometry for determination of pharmaceutical residues in surface sea water. Chemosphere 80(11): 1255-1260.
104. Mahnik SN, Rizovski B, Fuerhacker M, Mader RM (2006) Development of an analytical method for the determination of anthracyclines in hospital effluents. Chemosphere 65(8): 1419-1425.
105. Malik A, Aleem A (2011) Incidence of metal and antibiotic resistance in Pseudomonas spp. from the river water, agricultural soil irrigated with wastewater and groundwater. Environ Monit Assess 178(1-4): 293-308.
106. Martinez Bueno MJ, Dolores Hernando M, Herrera S, Jose Gomez M, Fernandez-Alba AR, Bustamante I, Garcia-Calvo E (2010) Pilot survey of chemical contaminants from industrial and human activities in river waters of Spain. Int J Environ Anal Chem 90(3-6): 321-343.
107. Martinez Galera M, Gil Garcia MD, Culzoni MJ, Goicoechea HC (2010) Determination of pharmaceuticals in river water by column switching of large sample volumes and liquid chromatography-diode array detection, assisted by chemometrics: an integrated approach to green analytical methodologies. J Chromatogr A 1217(13): 2042-2049.
108. Maskaoui K, Zhou JL (2010) Colloids as a sink for certain pharmaceuticals in the aquatic environment. Environ Sci Pollut Res 17(4): 898-907.
109. Matsuo H, Sakamoto H, Arizono K, Shinohara R (2011) Behavior of pharmaceuticals in waste water treatment plant in Japan. Bull Environ Contam Toxicol 87(1): 31-35.
110. Miege C, Budzinski H, Jacquet R, Soulier C, Pelte T, Coquery M (2012) Polar organic chemical integrative sampler (POCIS): application for monitoring organic micropollutants in wastewater effluent and surface water. J Environ Monit 14(2): 626-635.
111. Mueller B, Scheytt T, Asbrand M, de Casas AM (2012) Pharmaceuticals as indictors of sewage-influenced groundwater. Hydrogeol J 20(6): 1117-1129.
112. Murata A, Takada H, Mutoh K, Hosoda H, Harada A, Nakada N (2011) Nationwide monitoring of selected antibiotics: distribution and sources of sulfonamides, trimethoprim, and macrolides in Japanese rivers. Sci Total Environ 409(24): 5305-5312.
113. Murray KE, Thomas SM, Bodour AA (2010) Prioritizing research for trace pollutants and emerging contaminants in the freshwater environment. Environ Pollut 158(12): 3462-3471.
114. Nakada N, Komori K, Suzuki Y, Konishi C, Houwa I, Tanaka H (2007) Occurrence of 70 pharmaceutical and personal care products in Tone River basin in Japan. Water Sci Technol 56(12): 133-140.
115. Perez-Parada A, del Mar Gomez-Ramos M, Martinez Bueno MJ, Ucles S, Ucles A, Fernandez-Alba AR (2012) Analytical improvements of hybrid LC-MS/MS techniques for the efficient evaluation of emerging contaminants in river waters: a case study of the Henares River (Madrid, Spain). Environ Sci Pollut Res 19(2): 467-481.
116. Peschka M, Eubeler JP, Knepper TP (2006) Occurrence and fate of barbiturates in the aquatic environment. Environ Sci Technol 40(23): 7200-7206.
117. Pillai SD, Widmer KW, Maciorowski KG, Ricke SC (1997) Antibiotic resistance profiles of Escherichia coli isolated from rural and urban environments. J Environ Sci Health A Environ Sci Eng Toxicol 32(6): 1665-1675.
118. Poliwoda A, Krzyzak M, Wieczorek PP (2010) Supported liquid membrane extraction with single hollow fiber for the analysis of fluoroquinolones from environmental surface water samples. J Chromatogr A 1217(22): 3590-3597.
119. Quinn B, Gagne F, Blaise C (2008) An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuata. Sci Total Environ 389(2-3): 306-314.
120. Quoc Tuc D, Alliot F, Moreau-Guigon E, Eurin J, Chevreuil M, Labadie P (2011) Measurement of trace levels of antibiotics in river water using on-line enrichment and triple-quadrupole LC-MS/MS. Talanta 85(3): 1238-1245.
121. Ramaswamy BR, Shanmugam G, Velu G, Rengarajan B, Larsson DGJ (2011) GC-MS analysis and ecotoxicological risk assessment of triclosan, carbamazepine and parabens in Indian rivers. J Hazard Mater 186(2-3): 1586-1593.
122. Real FJ, Benitez FJ, Acero JL, Roldan G (2012) Combined chemical oxidation and membrane filtration techniques applied to the removal of some selected pharmaceuticals from water systems. J Environ Sci Health Part A 47(4): 522-533.
123. Roberts PH, Thomas KV (2006) The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci Total Environ 356(1-3): 143-153.
124. Rocco L, Frenzilli G, Fusco D, Peluso C, Stingo V (2010) Evaluation of zebrafish DNA integrity after exposure to pharmacological agents present in aquatic environments. Ecotoxicol Environ Saf 73(7): 1530-1536.
125. Rodil R, Benito Quintana J, Concha-Grana E, Lopez-Mahia P, Muniategui-Lorenzo S, Prada-Rodriguez D (2012) Emerging pollutants in sewage, surface and drinking water in Galicia (NW Spain). Chemosphere 86(10): 1040-1049.
126. Rosal R, Rodriguez A, Antonio Perdigon-Melon J, Petre A, Garcia-Calvo E, Jose Gomez M, Aguera A, Fernandez-Alba AR (2010) Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res 44(2): 578-588.
127. Rua-Gomez PC, Puettmann W (2012) Impact of wastewater treatment plant discharge of lidocaine, tramadol, venlafaxine and their metabolites on the quality of surface waters and groundwater. J Environ Monit 14(5): 1391-1399.
128. Samaras VG, Thomaidis NS, Stasinakis AS, Gatidou G, Lekkas TD (2010) Determination of selected non-steroidal anti-inflammatory drugs in wastewater by gas chromatography-mass spectrometry. Int J Environ Anal Chem 90(3-6): 219-229.
129. Sanderson H (2003) Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol Lett 144(3): 383-395.
130. Sanderson H, Johnson DJ, Reitsma T, Brain RA, Wilson CJ, Solomon KR (2004) Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regul Toxicol Pharmacol 39(2): 158-183.
131. Santos JL, Aparicio I, Alonso E (2007) Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ Int 33(4): 596-601.
132. Santos LHMLM, Araújo AN, Fachini A, Pena A, Delerue-Matos C, Montenegro MCBSM (2010) Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J Hazard Mater 175(1-3): 45-95.
133. Sayah RS, Kaneene JB, Johnson Y, Miller R (2005) Patterns of antimicrobial resistance observed in Escherichia coli isolates obtained from domestic- and wild-animal fecal samples, human septage, and surface water. Appl Environ Microbiol 71(3): 1394-1404.
134. Schulman LJ, Sargent EV, Naumann BD, Faria EC, Dolan DG, Wargo JP (2002) A human health risk assessment of pharmaceuticals in the aquatic environment. Hum Ecolog Risk Assess 8(4): 657-680.
135. Sim W-J, Lee J-W, Oh J-E (2010) Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea. Environ Pollut 158(5): 1938-1947.
136. Singh SP, Azua A, Chaudhary A, Khan S, Willett KL, Gardinali PR (2010) Occurrence and distribution of steroids, hormones and selected pharmaceuticals in South Florida coastal environments. Ecotoxicology 19(2): 338-350.
137. Spongberg AL, Witter JD, Acuna J, Vargas J, Murillo M, Umana G, Gomez E, Perez G (2011) Reconnaissance of selected PPCP compounds in Costa Rican surface waters. Water Res 45(20): 6709-6717.
138. Stoll C, Sidhu JPS, Tiehm A, Toze S (2012) Prevalence of clinically relevant antibiotic resistance genes in surface water samples collected from Germany and Australia. Environ Sci Technol 46(17): 9716-9726.
139. Straub JO (2002) Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001. Toxicol Lett 131(1-2): 137-143.
140. Sturini M, Speltini A, Maraschi F, Profumo A, Pretali L, Fasani E, Albini A (2010) Photochemical degradation of marbofloxacin and enrofloxacin in natural waters. Environ Sci Technol 44(12): 4564-4569.
141. Sui Q, Wang B, Zhao W, Huang J, Yu G, Deng S, Qiu Z, Lu S (2012) Identification of priority pharmaceuticals in the water environment of China. Chemosphere 89(3): 280-286.
142. Teijon G, Candela L, Tamoh K, Molina-Diaz A, Fernandez-Alba AR (2010) Occurrence of emerging contaminants, priority substances (2008/105/CE) and heavy metals in treated wastewater and groundwater at Depurbaix facility (Barcelona, Spain). Sci Total Environ 408(17): 3584-3595.
143. Tixier C, Singer HP, Oellers S, Muller SR (2003) Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ Sci Technol 37(6): 1061-1068.
144. van De Steene JC, Lambert WE (2011) Determination of four basic pharmaceuticals and one pesticide in surface water with UPLC-ESI-MS/MS. Int J Environ Anal Chem 91(12): 1218-1226.
145. van De Steene JC, Stove CP, Lambert WE (2010) A field study on 8 pharmaceuticals and 1 pesticide in Belgium: removal rates in waste water treatment plants and occurrence in surface water. Sci Total Environ 408(16): 3448-3453.
146. van Wezel AP, Jager T (2002) Comparison of two screening level risk assessment approaches for six disinfectants and pharmaceuticals. Chemosphere 47: 1113-1128.
147. Vasskog T, Anderssen T, Pedersen-Bjergaard S, Kallenborn R, Jensen E (2008) Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway. J Chromatogr A 1185(2): 194-205.
148. Vazquez-Roig P, Andreu V, Blasco C, Morillas F, Pico Y (2012a) Spatial distribution of illicit drugs in surface waters of the natural park of Pego-Oliva Marsh (Valencia, Spain). Environ Sci Pollut Res 19(4): 971-982.
149. Vazquez-Roig P, Andreu V, Blasco C, Picó Y (2012b) Risk assessment on the presence of pharmaceuticals in sediments, soils and waters of the Pego-Oliva Marshlands (Valencia, eastern Spain). Sci Total Environ 44: 24-32.
150. Velicu M, Suri R (2009) Presence of steroid hormones and antibiotics in surface water of agricultural, suburban and mixed-use areas. Environ Monit Assess 154(1-4): 349-359.
151. Verlicchi P, Al Aukidy M, Zambello E (2012) Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-a review. Sci Total Environ 429: 123-155.
152. Vieno NM, Tuhkanen T, Kronberg L (2005) Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ Sci Technol 39(21): 8220-8226.
153. Vignesh S, Muthukumar K, James RA (2012) Antibiotic resistant pathogens versus human impacts: a study from three eco-regions of the Chennai coast, southern India. Mar Pollut Bull 64(4): 790-800.
154. Vulliet E, Cren-Olivé C (2011) Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption. Environ Pollut 159(10): 2929-2934.
155. Vulliet E, Cren-Olive C, Grenier-Loustalot M-F (2011) Occurrence of pharmaceuticals and hormones in drinking water treated from surface waters. Environ Chem Lett 9(1): 103-114.
156. Vystavna Y, Huneau F, Grynenko V, Vergeles Y, Celle-Jeanton H, Tapie N, Budzinski H, Le Coustumer P (2012) Pharmaceuticals in rivers of two regions with contrasted socio-economic conditions: occurrence, accumulation, and comparison for Ukraine and France. Water Air Soil Pollut 223(5): 2111-2124.
157. Wang L, Ying GG, Zhao JL, Yang XB, Chen F, Tao R, Liu S, Zhou LJ (2010) Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of North China. Sci Total Environ 408(16): 3139-3147.
158. Wei R, Ge F, Chen M, Wang R (2012) Occurrence of ciprofloxacin, enrofloxacin, and florfenicol in animal wastewater and water resources. J Environ Qual 41(5): 1481-1486.
159. Wilson BA, Smith VH, Denovelles FJ (2003) Effects of three pharmaceutical and personal care products on natural freshwater algal assemblages. Environ Sci Technol 37: 1713-1719.
160. Yang JF, Ying GG, Zhao JL, Tao R, Su HC, Liu YS (2011) Spatial and seasonal distribution of selected antibiotics in surface waters of the Pearl Rivers, China. J Environ Sci Health Part B 46(3): 272-280.
161. Yin J, Meng Z, Du M, Liu C, Song M, Wang H (2010) Pseudo-template molecularly imprinted polymer for selective screening of trace beta-lactam antibiotics in river and tap water. J Chromatogr A 1217(33): 5420-5426.
162. Yu JT, Bisceglia KJ, Bouwer EJ, Roberts AL, Coelhan M (2012) Determination of pharmaceuticals and antiseptics in water by solid-phase extraction and gas chromatography/mass spectrometry: analysis via pentafluorobenzylation and stable isotope dilution. Anal Bioanal Chem 403(2): 583-591.
163. Zhang R, Zhang G, Tang J, Xu W, Li J, Liu X, Zou Y, Chen X, Li X (2012) Levels, spatial distribution and sources of selected antibiotics in the East River (Dongjiang), South China. Aquat Ecosyst Health Manag 15(2): 210-218.
164. Zhao JL, Ying GG, Wang L, Yang JF, Yang XB, Yang LH, Li X (2009) Determination of phenolic endocrine disrupting chemicals and acidic pharmaceuticals in surface water of the Pearl Rivers in South China by gas chromatography-negative chemical ionization-mass spectrometry. Sci Total Environ 407(2): 962-974.
165. Zheng S, Qiu X, Chen B, Yu X, Liu Z, Zhong G, Li H, Chen M, Sun G, Huang H, Yu W, Freestone D (2011) Antibiotics pollution in Jiulong River estuary: source, distribution and bacterial resistance. Chemosphere 84(11): 1677-1685.
166. Zhou H, Wu C, Huang X, Gao M, Wen X, Tsuno H, Tanaka H (2010) Occurrence of selected pharmaceuticals and caffeine in sewage treatment plants and receiving rivers in Beijing, China. Water Environ Res 82(11): 2239-2248.
167. Zhou JL, Zhang ZL, Banks E, Grover D, Jiang JQ (2009) Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water. J Hazard Mater 166(2-3): 655-661.
168. Zhou LJ, Ying GG, Zhao JL, Yang JF, Wang L, Yang B, Liu S (2011a) Trends in the occurrence of human and veterinary antibiotics in the sediments of the Yellow River, Hai River and Liao River in northern China. Environ Pollut 159(7): 1877-1885.
169. Zhou XF, Dai CM, Zhang YL, Surampalli RY, Zhang TC (2011b) A preliminary study on the occurrence and behavior of carbamazepine (CBZ) in aquatic environment of Yangtze River Delta, China. Environ Monit Assess 173(1-4): 45-53.
170. Zuccato E, Castiglioni S, Bagnati R, Melis M, Fanelli R (2010) Source, occurrence and fate of antibiotics in the Italian aquatic environment. J Hazard Mater 179(1-3): 1042-1048.
171. Zuccato E, Castiglioni S, Fanelli R (2005) Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. J Hazard Mater 122(3): 205-209.